ÂÜÀòÂÒÂ×

Brian McVeigh is the Chairman, Chief Executive Officer, and Co-Founder of Code BioTherapeutics, a biotechnology company focused on the targeted delivery of genetic medicines for serious genetic diseases. McVeigh also serves as the Executive Chairman and Co-Founder of 4BIO Capital, and the Chairman of the Board for Genisphere, as well as holding various senior advisory and board roles in companies such as SciNeuro Pharmaceuticals, SG3 Ventures LLC, and UPMC Enterprises. With a robust background in the life sciences sector, McVeigh has successfully led multiple companies through strategic transitions and financings. McVeigh holds a Bachelor of Science in Accounting and Finance from La Salle University, an MBA from Villanova University, and additional credentials in pharmaceutical marketing and professional development from prestigious institutions.